Our laboratory studies mechanisms of adaptation expressed by the bacterium and by the host macrophage during infection, with the goal of finding targets for therapeutic intervention. We also develop tools that may help identify latently infected individuals that are at high risk of developing active tuberculosis. Our expertise in antibody responses to tuberculosis has guided our current effort in studying the antibody response to SARS-CoV-2 and the seroepidemiology of COVID-19.